Incyte to pay $12.6 million to resolve drug charity kickback claims

Biopharmaceutical company Incyte Corp will pay $12.6 million to resolve allegations that it used a charity as a conduit to pay Medicare and Tricare patients kickbacks to use its cancer drug Jakafi, the U.S. Justice Department said on Tuesday.